Position in INVA
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$9,756,431
+$2,977,703 QoQ
Shares Held
418,731
+23.5% QoQ
Ownership
0.567%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,683,587,850 across 95 Biotechnology names. INVA ranks #35 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
896,397 | $205,032,885 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
426,523 | $190,459,579 | |
| 3 | INSM |
INSMED Inc
|
916,464 | $149,860,192 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
1,330,415 | $98,796,617 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
120,425 | $93,045,171 | |
| 6 | GPCR |
Structure Therapeutics Inc.
|
1,753,764 | $84,531,424 | |
| 7 | CYTK |
Cytokinetics Inc
|
1,093,485 | $72,071,595 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
350,488 | $59,239,481 |
All Filings in INVA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,756,431 | 418,731 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $6,778,728 | 339,106 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $5,287,480 | 289,725 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $6,302,232 | 313,700 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $5,538,279 | 305,476 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $5,166,412 | 297,776 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $5,537,663 | 286,777 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $5,032,094 | 306,835 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $4,937,622 | 323,991 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $5,178,834 | 322,870 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $4,292,895 | 330,477 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $4,449,770 | 349,550 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $4,409,966 | 391,997 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $5,337,444 | 402,826 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $4,850,773 | 417,810 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $6,951,604 | 470,976 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $9,616,621 | 496,983 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $9,208,809 | 533,844 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $9,133,401 | 546,583 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $7,457,126 | 556,087 | Shares | Defined | 2021-08-10 | |
| 2020-12-31 | $7,000,906 | 565,045 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $5,597,552 | 535,651 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $7,765,400 | 555,465 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $6,430,967 | 546,851 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||